help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, D.
Right arrow Articles by Reddy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, D.
Right arrow Articles by Reddy, S.

Am. J. Respir. Cell Mol. Biol., Volume 22, Number 1, January, 2000 92-96

Expression and Regulation of a Molecular Marker, SPR1, in Multistep Bronchial Carcinogenesis

Derick Lau, Ling Xue, Ruide Hu, Thomas Liaw, Reen Wu, and Sekhar Reddy*

University of California, Davis Cancer Center; and Veterans Administration Northern California Health Care System, Sacramento, California

A small proline-rich protein, SPR1, is overexpressed in squamous metaplasia of bronchial epithelium. We studied the expression and regulation of SPR1 in a series of human bronchial epithelial cell lines representing a model of multistep bronchial carcinogenesis. These cell lines included a primary culture of tracheobronchial epithelial cells (HTBE), a papilloma virus-transformed tracheobronchial epithelial cell line (HBE1), a cell line selected from HBE1 by a tobacco carcinogen and a phorbol ester (HBE1-C), a simian virus-transformed bronchial epithelial cell line (BEAS-2B), and a lung carcinoma cell line (H460). Different tumorigenic potentials of these cell lines were indicated by graded levels of telomerase activity. Concomitant with squamous transformation, there was an increase in SPR1 expression in HTBE, HBE1, and HBE1-C that was reversible by vitamin A. With progression of tumorigenicity, there was a marked reduction in SPR1 expression in BEAS-2B and a total loss of expression in H460. In these latter cell lines representing advanced malignant transformation, there was a loss of up- and downregulation, respectively, by the phorbol ester and vitamin A. Transfection study with chimeric constructs of the SPR1 promoter and a reporter gene showed that the dysregulation of SPR1 expression in malignant transformation was a result of perturbation of the basal and enhancer elements of the first 162 nucleotides in the 5'-flanking promoter region of the SPR1 gene. These findings suggest an association of transcriptional dysregulation of the SPR1 gene with multistep bronchial carcinogenesis.


* Current address: The Johns Hopkins School of Public Health, Dept. of Environmental Health Sciences, Div. of Physiology, Rm. W7006, 615 N. Wolfe St., Baltimore, MD 21205.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Tesfaigzi, P. S. Wright, and S. A. Belinsky
SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L889 - L898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Vuong, T. Patterson, P. Shapiro, D. V. Kalvakolanu, R. Wu, W.-Y. Ma, Z. Dong, S. R. Kleeberger, and S. P. M. Reddy
Phorbol Ester-induced Expression of Airway Squamous Cell Differentiation Marker, SPRR1B, Is Regulated by Protein Kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 Signal Transduction Pathway
J. Biol. Chem., October 6, 2000; 275(41): 32250 - 32259.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.
  Tobacco